MLTX
Price
$52.99
Change
-$3.31 (-5.88%)
Updated
Dec 18, 04:23 PM (EDT)
96 days until earnings call
PHVS
Price
$18.50
Change
+$0.01 (+0.05%)
Updated
Dec 18, 04:59 PM (EDT)
127 days until earnings call
Ad is loading...

MLTX vs PHVS

Header iconMLTX vs PHVS Comparison
Open Charts MLTX vs PHVSBanner chart's image
MoonLake Immunotherapeutics
Price$52.99
Change-$3.31 (-5.88%)
Volume$100
CapitalizationN/A
Pharvaris
Price$18.50
Change+$0.01 (+0.05%)
Volume$4.8K
CapitalizationN/A
MLTX vs PHVS Comparison Chart
Loading...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLTX vs. PHVS commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a Buy and PHVS is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (MLTX: $56.30 vs. PHVS: $18.49)
Brand notoriety: MLTX and PHVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 174% vs. PHVS: 50%
Market capitalization -- MLTX: $3.55B vs. PHVS: $1B
MLTX [@Biotechnology] is valued at $3.55B. PHVS’s [@Biotechnology] market capitalization is $1B. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 0 FA rating(s) are green whilePHVS’s FA Score has 0 green FA rating(s).

  • MLTX’s FA Score: 0 green, 5 red.
  • PHVS’s FA Score: 0 green, 5 red.
According to our system of comparison, MLTX is a better buy in the long-term than PHVS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 5 TA indicator(s) are bullish while PHVS’s TA Score has 3 bullish TA indicator(s).

  • MLTX’s TA Score: 5 bullish, 5 bearish.
  • PHVS’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than PHVS.

Price Growth

MLTX (@Biotechnology) experienced а +4.55% price change this week, while PHVS (@Biotechnology) price change was +1.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

MLTX is expected to report earnings on Mar 24, 2025.

PHVS is expected to report earnings on Apr 24, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($3.55B) has a higher market cap than PHVS($1B). MLTX YTD gains are higher at: -6.773 vs. PHVS (-34.082). MLTX has higher annual earnings (EBITDA): -108.45M vs. PHVS (-127.53M). MLTX has more cash in the bank: 494M vs. PHVS (305M). PHVS has less debt than MLTX: PHVS (117K) vs MLTX (3.69M). MLTX (0) and PHVS (0) have equivalent revenues.
MLTXPHVSMLTX / PHVS
Capitalization3.55B1B354%
EBITDA-108.45M-127.53M85%
Gain YTD-6.773-34.08220%
P/E RatioN/AN/A-
Revenue00-
Total Cash494M305M162%
Total Debt3.69M117K3,152%
TECHNICAL ANALYSIS
Technical Analysis
MLTXPHVS
RSI
ODDS (%)
Bearish Trend 6 days ago
74%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 15 days ago
78%
Declines
ODDS (%)
Bearish Trend 23 days ago
70%
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FGFAX36.51-0.19
-0.52%
Federated Hermes International Leaders A
LIDOX8.09-0.06
-0.74%
Lord Abbett International Value F3
RWMBX64.29-0.50
-0.77%
American Funds Washington Mutual R2
LMVFX121.04-1.17
-0.96%
ClearBridge Value FI
LGSCX12.98-0.63
-4.63%
Franklin U.S. Small Cap Equity FI

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with XENE. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+6.27%
XENE - MLTX
40%
Loosely correlated
-0.07%
EDIT - MLTX
40%
Loosely correlated
+2.70%
DNLI - MLTX
38%
Loosely correlated
-0.30%
AXSM - MLTX
38%
Loosely correlated
+4.27%
BEAM - MLTX
38%
Loosely correlated
-1.21%
More